Detection of placental growth hormone variant and chorionic somatomammotropin-L RNA expression in normal and diabetic pregnancy by reverse transcriptase-polymerase chain reaction

Molecular and Cellular Endocrinology

Volumn 157, Issue 1-2, 1999, Pages 131-142

  Hu, Limei ^a   Lytras, Aristides ^a   Bock, Margaret E ^a   Yuen, Chui Kin ^a   Dodd, Janice G ^a   Cattini, Peter A ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Gestational diabetes; Human growth hormone and chorionic somatomammotropin gene family; PCR; Placenta

Indexed keywords

GROWTH HORMONE; PLACENTA LACTOGEN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIABILITY; HUMAN TISSUE; MULTIGENE FAMILY; PLACENTA; POLYMERASE CHAIN REACTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; GROWTH HORMONE; HUMANS; PLACENTA; PLACENTAL HORMONES; PLACENTAL LACTOGEN; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS; VARIATION (GENETICS);

EID: 0032743374     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00152-5     Document Type: Article

References (58)

1. Barros L.F., Yudilevich D.L., Jarvis S.M., Beaumont N., Baldwin S.A. Quantitation and immunolocalization of glucose transporters in the human placenta. Placenta. 16:1995;623-633.
2. Bhaumick B., Dawson E.P., Bala R.M. The effects of insulin-like growth factor-I and insulin on placental lactogen production by human term placental explants. Biochem. Biophys. Res. Commun. 144:1987;674-682.
3. Bjork O., Persson B. Villous structure in different parts of the cotyledon in placentas of insulin-dependent diabetic women: a morphometric study. Acta. Obstet. Gynecol. Scand. 63:1984;37-43.
4. Boden G. Fuel metabolism in pregnancy and in gestational diabetes mellitus. Obst. Gynecol. Clin. North Am. 23:1996;1-10.
5. Botta R.M., Donatelli M., Bucalo M.L., Bellomonte M.L., Bompiani G.D. Placental lactogen, progesterone, total estriol and prolactin plasma levels in pregnant women with insulin-dependent diabetes mellitus. Eur. J. Obstet. Gynecol. Reprod. Biol. 16:1984;393-401.
6. Boyd P.A., Scott A., Keeling J.W. Quantitative structural studies on placentas from pregnancies complicated by diabetes mellitus. Br. J. Obstet. Gynaecol. 93:1986;31-35.
7. Carter J.E. Morphologic evidence of syncytial formation from the cytotrophoblastic cells. Obstet. Gynecol. 23:1964;647-656.
8. Caufriez A., Frankenne F., Hennen G., Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am. J. Physiol. 265:1993;E572-E577.
9. Chiasson J.L., el Achkar G.G., Ducros F., Bourque J., Maheux P. Glucose turnover and gluconeogenesis during pregnancy in women with and without insulin-dependent diabetes mellitus. Clin. Invest. Med. 20:1997;140-151.
10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid-guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
11. Daikoku N.H., Tyson J.E., Graf C., Scott R., Smith B., Johnson J.W. et al. The relative significance of human placental lactogen in the diagnosis of retarded fetal growth. Am. J. Obstet. Gynecol. 135:1979;516-521.
12. Das U.G., Sadiq H.F., Soares M.J., Hay W.W.-Jr., Devaskar S.U. Time-dependent physiological regulation of rodent and ovine placental glucose transporter (GLUT- 1) protein. Am. J. Physiol. 274:1998;R339-R347.
13. Enders A.C. Formation of syncytium from cytotrophoblast in the human placenta. Obstet. Gynecol. 25:1964;378-386.
14. Fisher P.M., Sutherland H.W., Bewsher P.D. The insulin response to glucose infusion in gestational diabetes. Diabetologia. 19:1980;10-14.
15. Fisher P.M., Sutherland H.W., Bewsher P.D. The insulin response to glucose infusion in normal human pregnancy. Diabetologia. 19:1980;15-20.
16. Frankenne F., Closset J., Gomez F., Scippo M.L., Smal J., Hennen G.J. The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J. Clin. Endocrinol. Metab. 66:1988;1171-1180.
17. Friesen H.G. Human placental lactogen and human pituitary prolactin. Clin. Obstet. Gynecol. 14:1971;669-684.
18. Frohman M.A., Dush M.K., Martin G.R. Rapid production of full length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc. Natl. Acad. Sci. USA. 85:1988;8998-9002.
19. Gordon M.C., Zimmerman P.D., Landon M.B., Gabbe S.G., Kniss D.A. Insulin and glucose modulate glucose transporter messenger ribonucleic acid expression and glucose uptake in trophoblasts isolated from first-trimester chorionic villi. Am. J. Obstet. Gynecol. 173:1995;1089-1097.
20. Gosseye S., van der Veen F. HPL-positive infiltrating trophoblastic cells in normal and abnormal pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 44:1992;85-90.
21. Greco M.A., Kamat B.R., Demopoulos R.I. Placental protein distribution in maternal diabetes mellitus: an immunocytochemical study. Pediatr. Patho. 19:1989;679-690.
22. Handwerger S. Clinical counterpoint: the physiology of placental lactogen in human pregnancy. Endocrine Rev. 12:1991;329-336.
23. Haugel-de Mouzon S., Leturque A., Alsat E., Loizeau M., Evain-Brion D., Girard J. Developmental expression of Glut1 glucose transporter and c-fos genes in human placental cells. Placenta. 15:1994;35-46.
24. Hennen G., Frankenne F., Closset J., Gomez F., Pirens G., Khayat N.E. A human placental GH: increasing levels during second half of pregnancy with pituitary GH supression as revealed by monoclonal antibody radioimmunoassays. Int. J. Fertil. 30:1985;27-33.
25. Honda M., Toyoda C., Nakabayashi M., Omori Y. Quantitative investigations of placental terminal villi in maternal diabetes mellitus by scanning and transmission electron microscopy. Tohoku J. Exp. Med. 167:1992;247-257.
26. Jones C.J., Fox H. An ultrastructural and ultrahistochemical study of the placenta of the diabetic woman. J. Pathol. 119:1976;91-99.
27. Khong T.Y., Pearce J.M. Development and investigation of the placenta and its blood supply. Lavery P.J. The Human Placenta: Clinical Perspectives. 1987;25-45 Aspen Publishers, Salem, Massachusetts.
28. Letchworth A.T., Slattery M., Dennis K.J. Clinical application of human placental lactogen values in late pregnancy. Lancet. 1:1978;955-957.
29. Lopez-Espinoza I., Smith R.F., Gillmer M., Schidlmeir A., Hockaday T.D. High levels of growth hormone and human placental lactogen in pregnancy complicated by diabetes. Diabetes Res. 3:1986;119-125.
30. Lytras A., Bock M.E., Dodd J.G., Cattini P.A. Differential placental growth hormone variant expression and chorionic somatomammotropin gene expression in human trophoblast neoplasms by reverse transcriptase-polymerase chain reaction. Endocrinology. 134:1994;2461-2469.
31. MacLeod J.N., Lee A.K., Liebhaber S.A., Cooke N.E. Developmental control and alternative splicing of the placentally expressed transcripts from the human growth hormone gene cluster. J. Biol. Chem. 267:1992;14219-14226.
32. Martinez-Rodriguez H.G., Guerra-Rodriguez N.E., Iturbe-Cantu M.A., Martinez Torres A., Barrera Saldana H.A. Expression of human placental lactogen and variant growth hormone genes in placenta. Arch. Med. Res. 28:1997;507-512.
33. Mestman J.H., Schmidt-Sarosi C. Diabetes mellitus and fertility control: contraception management issues. Am. J. Obstet. Gynecol. 168:1993;2012-2020.
34. Mills N.C., Gyves M.T., Ilan J. Comparisons of human placental lactogen mRNA levels from placentas of diabetics and normal term. Mol. Cell. Endocrinol. 39:1985;61-69.
35. Morrison I., Green P., Oomen B. The role of human placental lactogen assays in antepartum fetal assessment. Am. J. Obstet. Gynecol. 136:1980;1055-1060.
36. Nickel B.E., Cattini P.A. Tissue-specific expression and thyroid hormone regulation of the endogenous placental growth hormone variant and chorionic somatomammotropin genes in a human choriocarcinoma cell line. Endocrinology. 128:1991;2353-2359.
37. Nickel B.E., Kardami E., Cattini P.A. Differential expression of human placental growth hormone variant and chorionic somatomammotropin in culture. Biochem. J. 267:1990;653-658.
38. Nisbet A.D., Horne C.H., Jandial V., Bremner R.D., Cruickshank N., Sutcliffe R.G. Measurement of plasma placental proteins and estriol in the detection of intrauterine growth retardation. Eur. J. Obstet. Gynecol. Reprod. Biol. 13:1982;333-342.
39. Padykula H.A. The human placenta. Weiss L. Histology: Cell and Tissue Biology. 1988;900-927 Elsevier Biomedical, New York, Amsterdam, Oxford.
40. Panigel M. The human placenta: 1. Anatomy and morphology. Chard T. Clinics in Obstetrics and Gynecology. 13:1986;421 W.B. Saunders Company, London.
41. Persson B., Hanson U., Marcus C. Gestational diabetes mellitus and paradoxical fetal macrosomia-a case report. Early Hum. Dev. 41:1995;203-213.
42. 1-glycoprotein in pregnant diabetic women. Br. J. Obstet. Gynaecol. 89:1982;827-830.
43. Prieto Villapun J.C., Cifuentes de Castro I., Serrano Rios M. Human chorionic somatomammotropin (HCS) and pregnancy: its relation with insulin. Reproduction. 3:1976;305-312.
44. Reece E.A., Eriksson U.J. The pathogenesis of diabetes-associated congenital malformations. Obst. Gynecol. Clin. North Am. 23:1996;29-45.
45. Ros H.S., Cnattingius S., Lipworth L. Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am. J. Epidemiol. 147:1998;1062-1070.
46. Scippo M.L., Frankenne F., Hooghe-Peters E.L., Igout A., Velkeniers B., Hennen G. Syncytiotrophoblastic localization of the human growth variant mRNA in the placenta. Mol. Cell. Endocrinol. 92:1993;R7-R13.
47. Steel J.M., Johnstone F.D. Guidelines for the management of insulin-dependent diabetes mellitus in pregnancy. Drugs. 52:1996;60-70.
48. Stewart M.O., Whittaker P.G., Persson B., Hanson U., Lind T. A longitudinal study of circulating progesterone, oestradiol, hCG and hPL during pregnancy in type 1 diabetic mothers. Br. J. Obstet. Gynaecol. 96:1989;415-423.
49. Stoz F., Schuhmann R.A., Haas B. Morphohistometric investigations in placentas of gestational diabetes. J. Perinat. Med. 16:1988;205-209.
50. Stoz F., Schuhmann R.A., Schmid A. Morphometric investigations of terminal villi of diabetic placentas in relation to the White classification of diabetes mellitus. J. Perinat. Med. 15:1987;193-198.
51. Teasdale F., Jean-Jacques G. Morphometry of the microvillous membrane of the human placenta in maternal diabetes mellitus. Placenta. 7:1986;81-88.
52. Terzakis J.A. The ultrastructure of normal human first trimester placenta. J. Ultrastruct. Res. 9:1963;268-284.
53. Tyrala E.E. The infant of the diabetic mother. Obst. Gynecol. Clin. North Am. 23:1996;221-241.
54. Ursell W., Brudenell M., Chard T. Placental lactogen levels in diabetic pregnancy. BMJ. 2:1973;80-82.
55. Van Beek E., Peeters L.L. Pathogenesis of preeclampsia: a comprehensive model. Obstet. Gynecol. Surv. 53:1998;233-239.
56. Zhou Y., Damsky C.H., Fisher S.J. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome? J. Clin. Invest. 99:1997a;2152-2164.
57. Zhou Y., Fisher S.J., Janatpour M., Genbacev O., Dejana E., Wheelock M. et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate: a strategy for successful endovascular invasion? J. Clin. Invest. 99:1997b;2139-2151.
58. Zhu L., Nakabayashi M., Takeda Y. Statistical analysis of perinatal outcomes in pregnancy complicated with diabetes mellitus. J. Obstet. Gynecol. Res. 23:1997;555-563.